mRNA drug offers hope for treating a devastating childhood disease
Drug trial results show that vaccines aren’t the only use for the mRNA technology behind the most widely used COVID-19 jabs....
Drug trial results show that vaccines aren’t the only use for the mRNA technology behind the most widely used COVID-19 jabs....
With key long COVID trials yet to yield results, people with the condition are trying to change how clinical trials are done....
Georgia Institute of Technology Scientists, in collaboration with investigators from University of Wisconsin—Madison as well as University of Tokyo continued pursuing the optimal coronavirus vaccine since the Covid-19 pandemic started....
Researchers at the University of Wisconsin School of Medicine and Public Health are exploring the ideal vaccine booster strategy for immunosuppressed patients to protect those at higher risk of severe illness and complications from COVID-19 infection....
The COVID-19 pandemic opened the door for some significant and noteworthy changes to the way our industry could accomplish clinical trials with a forced mandate to decentralize access and services for the continuation of studies....
The effectiveness of mRNA vaccines in reducing disease severity and hospitalization from COVID-19 is well established. Now, new research from the University of Wisconsin School of Veterinary Medicine advances our understanding of how these vaccines protect the lungs following breakthrough infections from emerging variants of...
Researchers at the University of Wisconsin School of Medicine and Public Health are investigating how well the updated monovalent COVID-19 vaccines work for inflammatory bowel disease patients....
Vaccines for heart disease and cancer could help combat these diseases and advance researchers' understanding of the human body, but are they the magic cure-all many expect them to be?...
Patients and those with affected family or community members have joined researchers, clinicians, and experts in their efforts to unlock the mysteries of Long COVID....
Decentralized clinical trials rose in prominence during the COVID-19 pandemic. Are they here to stay?...